Tecan Launches Air Restriction Pipettor Option for Cavro OEM Liquid Handling Robotic Platform (832-20)
UNITED KINGDOM / AGILITYPR.NEWS / January 26, 2021 / Tecan has expanded the range of pipetting options for its Cavro® Magni Flex OEM liquid handling framework with the creation of the Air Restriction Pipettor (ARP). Complementing the existing liquid displacement option based on the Cavro Pulssar PBC Pump, this new offering is well suited to molecular biology, immunoassay and genomics applications – including molecular diagnostics – increasing the potential range of applications for this versatile development platform.
Launched in 2019, the modular and scalable Magni Flex has already proven popular for instrument development applications, with a range of sizes and options to match the needs of specific workflows. By offering a choice of liquid or air displacement pipetting using fixed or disposable tips, Tecan has now further extended the versatility of this OEM development platform. The new ARP Technology™ provides the broadest volume range on the market – from 1 μl up to 5 ml – for two, four or eight independent pipetting channels with variable tip spacing capabilities. It uses built-in temperature and pressure sensors to automatically adjust to varying liquid viscosities and types, as well as atmospheric conditions, to ensure reproducible and reliable liquid transfers. Combined with Tecan’s MAPlinx™ Software, a powerful tool to streamline and simplify instrument development, the Cavro Magni Flex provides a versatile solution for the automation of liquid handling workflows, backed by Tecan’s 40+ years of industry expertise.
To learn more about the Cavro Magni Flex featuring the ARP, visit www.tecan.com/magni-flex-features or visit our virtual booth at SLAS2021.
About Us
Tecan is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics and clinical diagnostics. The company specializes in the development, production and distribution of automated workflow solutions for laboratories in the life sciences sector. Its clients include pharmaceutical and biotechnology companies, university research departments, forensic and diagnostic laboratories. As an original equipment manufacturer (OEM), Tecan is also a leader in developing and manufacturing OEM instruments and components that are then distributed by partner companies. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both Europe and North America and maintains a sales and service network in 52 countries. In 2019, Tecan generated sales of CHF 637 million (USD 643 million; EUR 574 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TECN; ISIN CH0012100191).
Tecan ist ein weltweit führender Anbieter von Laborinstrumenten und Lösungen für die Branchen Biopharma, Forensik und Klinische Diagnostik. Das Unternehmen ist auf Entwicklung, Herstellung und Vertrieb von Automatisierungslösungen für Laboratorien im Life-Science-Bereich spezialisiert. Die Kunden von Tecan sind Pharma- und Biotechnologieunternehmen, Forschungs-abteilungen von Universitäten sowie forensische und diagnostische Laboratorien. Als Originalgeräte-hersteller (OEM) ist Tecan auch führend in der Entwicklung und Herstellung von OEM-Instrumenten und Komponenten, die vom jeweiligen Partnerunternehmen vertrieben werden. Tecan wurde 1980 in der Schweiz gegründet. Das Unternehmen verfügt über Produktions-, Forschungs- und Entwicklungs-stätten in Europa und in Nordamerika. In 52 Ländern unterhält es ein Vertriebs- und Servicenetz. Im Jahr 2019 erzielte Tecan einen Umsatz von CHF 637 Mio. (USD 643 Mio.; EUR 574 Mio.). Die Namenaktien der Tecan Group werden an der SIX Swiss Exchange gehandelt (TECN; ISIN CH0012100191).
Contacts
Sarah Ballard
ideas@kdm-communications.comkdm communications limited, St Neots, UK
Phone: +44 (0) 1480 405333
Links